Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule

Biotech company Korro Bio announces stock option grant to new employee as part of hiring incentive.

Apr. 13, 2026 at 3:56am

Got story updates? Submit your updates here. ›

A minimalist, high-contrast studio photograph of a modern desk organizer made of brushed aluminum and glass, conveying the precision and innovation of Korro Bio's RNA editing technology.Korro Bio's cutting-edge RNA editing platform aims to unlock new possibilities in genetic medicine development.Cambridge Today

Korro Bio, a biopharmaceutical company developing genetic medicines based on RNA editing, has announced the grant of a non-statutory stock option to a newly hired employee. The option is for 15,000 shares at an exercise price of $13.46 per share, with a 10-year term and 4-year vesting schedule.

Why it matters

Inducement grants like this are common in the biotech industry as a way to attract and retain top talent. They provide a financial incentive for new hires to stay with the company long-term and contribute to its success.

The details

The stock option was granted to the new employee on April 8, 2026 and was approved by a majority of Korro Bio's independent directors under the company's 2026 Inducement Plan. The option has a 10-year term and vests over 4 years, with 25% of the shares vesting on the first anniversary of the employee's start date and the remaining 75% vesting in 36 equal monthly installments.

  • Korro Bio granted the stock option on April 8, 2026.
  • The new employee's start date was the vesting commencement date for the option.

The players

Korro Bio, Inc.

A biopharmaceutical company developing genetic medicines based on RNA editing for rare and prevalent diseases.

Nasdaq

The stock exchange where Korro Bio's shares trade under the ticker symbol KRRO.

Got photos? Submit your photos here. ›

The takeaway

Korro Bio's inducement grant to a new employee demonstrates the company's commitment to attracting top talent in the competitive biotech industry. These types of equity incentives are a common practice to incentivize long-term employee retention and alignment with shareholder interests.